COMMUNIQUÉS West-GlobeNewswire

NÉOVACS RENFORCE SA PROPRIÉTÉ INTELLECTUELLE AUX ÉTATS-UNIS
22/02/2018
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS RENFORCE SA PROPRI É T É INTELLECTUELLE AUX ÉTATS-UNIS Ce brevet porte sur l'IFNalpha Kinoïde et son utilisation dans les maladies liées à la [...]
Santhera Completes Capital Increase to Settle Obtained License from Polyphor
22/02/2018
Pratteln, Switzerland, February 22, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that its share capital recorded in the commercial register was increased from 6,279,857 shares by 247,622 shares to 6,527,479 [...]
ABLYNX ANNOUNCES 2017 FULL YEAR RESULTS
22/02/2018
REGULATED INFORMATION A year of many momentous moments GHENT, Belgium, 22 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced its financial results for the year ended 31 st December 2017, which [...]
MDxHealth_FY_Results EN
22/02/2018
NEWS RELEASE REGULATED INFORMATION ANNUAL FINANCIAL REPORT MDxHealth Reports Financial Year 2017 Results Product revenue of $28 million up 13% and total revenue of $40 million up 35% with continued strong volume growth [...]
MDxHealth_FY_Results FR
22/02/2018
COMMUNIQUÉ DE PRESSE INFORMATION REGLEMENTÉE RAPPORT FINANCIER ANNUEL MDxHealth communique ses résultats financiers pour l'exercice 2017 Le chiffre d'affaires total est en hausse de 35 % et les revenus liés aux produits [...]
Biocartis Group NV: Biocartis to host webcast for announcement 2017 financial results on 1 March 2018
22/02/2018
PRESS RELEASE: REGULATED INFORMATION 22 February 2018, 07:00 CET BioCARTIS to Host Webcast FOR ANNOUNCEMENT 2017 FINANCIAL Results on 1 March 2018 Mechelen, Belgium, 22 February 2018 - Biocartis Group NV (the 'Company' [...]
argenx to host conference call & webcast to report fourth quarter business update and full year 2017 financial results on March 1, 2018
22/02/2018
February 22, 2018 Breda, the Netherlands / Ghent, Belgium argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
22/02/2018
COPENHAGEN, Denmark, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a clinical stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 3,947,368 [...]
Primary Endpoint Successfully Achieved in Mesoblast’s Phase 3 Cell Therapy Trial for Acute Graft Versus Host Disease
22/02/2018
NEW YORK and MELBOURNE, Australia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) today announced that the Phase 3 trial of its allogeneic mesenchymal stem cell product candidate MSC-100- [...]
Genesis Announces New Financing Commitments and Provides Updates to Previously Announced Restructuring Plans
21/02/2018
$70 Million of Additional Liquidity from New and Expanded Loan Commitments $54 Million of Annual Lease Reductions Effective January 1, 2018 KENNETT SQUARE, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare (NYSE [...]
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
21/02/2018
BRIDGEWATER, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the granting of [...]
Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine
21/02/2018
– Marked and Durable Responses Across TRK Fusion Cancers – – 75 Percent Overall Response Rate by Central Assessment; 80 Percent Overall Response Rate by Investigator Assessment – – 86 Percent of Responding Patients [...]
Integra LifeSciences to Present at Healthcare Conferences in March 2018
21/02/2018
PLAINSBORO, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will present at the following healthcare conferences in March: [...]
SeaSpine to Report Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
21/02/2018
CARLSBAD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
21/02/2018
CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced the closing of its previously announced offering of common stock. The Company issued a total of 19,354,839 shares in [...]
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until March 9, 2018
21/02/2018
3 of 4 Proposals pass with stockholder approval Annual Meeting adjourned solely with respect to Proposal 4 - Approval of Reverse Stock Split EDISON, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc [...]
Globus Medical Reports Full Year and Fourth Quarter 2017 Results
21/02/2018
AUDUBON, Pa., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, [...]
LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)
21/02/2018
BURLINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27 [...]
Atara Biotherapeutics Announces Chief Financial Officer Intention to Retire in April 2018
21/02/2018
Launches Search for Chief Financial Officer SOUTH SAN FRANCISCO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing [...]

Pages